Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Illumigyn

company

About

Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications.

  • Neve Ilan,Yerushalayim,Israel
  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$33M
Industries
Artificial Intelligence,Health Care,Health Diagnostics,Medical Device,Product Design
Founded date
Dec 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Illumigyn incorporates existing machine vision technologies into a compact imaging colposcope for medical applications in an effort to eliminate the inherent subjectivity of cervical exams. Its Gynescope is a patented imaging colposcope that delivers 15-micron image resolution over a wide field of view and a range of working distances. The Gynescope also has multispectral illumination options, allowing early detection of cervical cancer while meaningfully reducing misdiagnoses. The Gynescope enables sophisticated imaging with simultaneous complex interventional procedures to support the best clinical outcomes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$33M
Illumigyn has raised a total of $33M in funding over 2 rounds. Their latest funding was raised on Nov 3, 2021 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 3, 2021 Series Unknown $33M 2 Ubicom Holdings
Yozma Group
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Illumigyn is funded by 2 investors. Ubicom Holdings and Yozma Group are the most recent investors.
Investor Name Lead Investor Funding Round
Ubicom Holdings Yes Series Unknown
Yozma Group Yes Series Unknown

Employee Profiles

Number of Employee Profiles
3
Illumigyn has 3 current employee profiles, including Executive Ran Poliakine
Executive
Executive
Executive